minocycline hydrochloride tablet, extended release
zydus pharmaceuticals (usa) inc. - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - minocycline 45 mg - minocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. safety of minocycline hydrochloride extended-release tablets has not been established beyond 12 weeks of use. this formulation of minocycline has not been evaluated in the treatment of infections [see clinical studies (14)]. to reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, minocycline hydrochloride extended-release tablets should be used only as indicated [see warnings and precautions (5.11)]. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. minocycline hydrochloride extended-release tablets should not be used during pregnancy. if the patient becomes pregnant while taking this drug, the
minocycline hydrochloride tablet, extended release
cadila healthcare limited - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - minocycline 45 mg - minocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. safety of minocycline hydrochloride extended-release tablets has not been established beyond 12 weeks of use. this formulation of minocycline has not been evaluated in the treatment of infections [see clinical studies (14)]. to reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, minocycline hydrochloride extended-release tablets should be used only as indicated [see warnings and precautions (5.11)]. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. minocycline hydrochloride extended-release tablets should not be used during pregnancy. if the patient becomes pregnant while taking this drug, the
minocycline 100mg (as hydrochloride) tablet bulk (af)
alphapharm pty ltd - minocycline hydrochloride dihydrate, quantity: 108 mg (equivalent: minocycline, qty 100 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; povidone; microcrystalline cellulose; sodium lauryl sulfate; magnesium stearate; carnauba wax; hypromellose; titanium dioxide; quinoline yellow; polyethylene; sunset yellow fcf; indigo carmine; macrogol 400
akamin 100 minocycline (as hydrochloride) 100mg capsule blister pack
alphapharm pty ltd - minocycline hydrochloride dihydrate -
minocin sa 100 mg modified release capsules
imed healthcare ltd. - minocycline - modified-release capsule, hard - 100 milligram(s) - tetracyclines; minocycline
minocycline hydrochloride- minocycline hydrochloride capsule
lake erie medical dba quality care products llc - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - minocycline 100 mg - indications and usage minocycline hydrochloride capsules are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox and tick fevers caused by rickettsiae. rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis. lymphogranuloma venereum caused by chlamydia trachomatis. - psittacosis (ornithosis) due to chlamydia psittaci. psittacosis (ornithosis) due to chlamydia psittaci. - trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminat
arestin microspheres powder (extended release)
ora pharma inc. - minocycline (minocycline hydrochloride) - powder (extended release) - 1mg - minocycline (minocycline hydrochloride) 1mg - antibacterials
ran-minocycline capsule
ranbaxy pharmaceuticals canada inc. - minocycline (minocycline hydrochloride) - capsule - 50mg - minocycline (minocycline hydrochloride) 50mg - tetracyclines
ran-minocycline capsule
ranbaxy pharmaceuticals canada inc. - minocycline (minocycline hydrochloride) - capsule - 100mg - minocycline (minocycline hydrochloride) 100mg - tetracyclines
minocycline hydrochloride- minocycline hydrochloride tablet, film coated
indicus pharma llc - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - tablet, film coated - 50 mg - minocycline hydrochloride tablets are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox and tick fevers caused by rickettsiae . respiratory tract infections caused by mycoplasma pneumoniae . lymphogranuloma venereum caused by chlamydia trachomatis . psittacosis (ornithosis) due to chlamydia psittaci . trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunoflourescence. inclusion conjunctivitis caused by chlamydia trachomatis . nongonococcal urethritis, endocervical, or rectal infections in adults caused by ureaplasma urealyticum or chlamydia trachomatis . relapsing fever due to borrelia recurrentis . chancroid caused by haemophilus ducreyi . plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infect